CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | Kalayoglu Murat 10% owner | Option exercise | +758,001 | 5,313,261 | ||
| 2026-04-02 | Kalayoglu Murat 10% owner | Option exercise · Series A Non-Voting Convertible Preferred Stock | −22,740.03 | 33,662.22 | ||
| 2026-01-02 | Kalayoglu Murat Director | Grant or award | +2,600 | 511,577 | ||
| 2026-01-02 | Kalayoglu Murat Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2025-01-02 | Kalayoglu Murat Director | Grant or award | +2,600 | 508,977 | ||
| 2025-01-02 | Kalayoglu Murat Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2024-10-11 | Kalayoglu Murat Director | Option exercise | +1,518,373 | 4,555,260 | ||
| 2024-10-11 | Kalayoglu Murat Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −45,551.19 | 56,402.25 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise | +491,853 | 506,377 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise | +2,926,764 | 3,036,887 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −14,755.61 | 0 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −87,802.95 | 101,953.44 | ||
| 2024-01-02 | Kalayoglu Murat Director | Grant or award | +178,000 | 435,739 | ||
| 2024-01-02 | Kalayoglu Murat Director | Grant or award · Stock Option (Right to Buy) | +228,000 | 228,000 | ||
| 2023-11-13 | Kalayoglu Murat Director | Grant or award | +257,739 | 257,739 | ||
| 2023-11-13 | Kalayoglu Murat Director | Other acquisition | +3,303,699 | 3,303,699 | ||
| 2023-11-13 | Kalayoglu Murat Director | Grant or award · Series A Non-Voting Convertible Preferred Stock | +14,755.61 | 14,755.61 | ||
| 2023-11-13 | Kalayoglu Murat Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +189,136.77 | 189,136.77 | ||
| 2023-11-13 | Kalayoglu Murat Director | Purchase · Series A Non-Voting Convertible Preferred Stock | +619.63 | $249,999.98 | $154.9M | 619.63 |
Page 1 of 1 · 19 trades